Negative regulation of C/EBPbeta1 by sumoylation in breast cancer cells

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Atwood, Allison A ^a   Jerrell, Rachel ^a   Sealy, Linda ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN BETA1; MITOGEN ACTIVATED PROTEIN KINASE 1; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; THREONINE; UNCLASSIFIED DRUG; C/EBPBETA1 PROTEIN, HUMAN; CCAAT ENHANCER BINDING PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL AGING; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SUMOYLATION; BREAST TUMOR; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; HUMANS; IMMUNOPRECIPITATION; PHOSPHORYLATION; SUMOYLATION;

EID: 80053220052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025205     Document Type: Article

References (39)

1. Kim KI, Baek SH, (2009) Small ubiquitin-like modifiers in cellular malignancy and metastasis. Int Rev Cell Mol Biol 273: 265-311.
2. Wang CY, She JX, (2008) SUMO-4 and its role in type 1 diabetes pathogenesis. Diabetes Metab Res Rev 24: 93-102.
3. Sarge KD, Park-Sarge OK, (2009) Sumoylation and human disease pathogenesis. Trends Biochem Sci 34: 200-5.
4. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Bio 8: 947-56.
5. Johnson E, (2004) Protein Modification by SUMO. Annu Rev Biochem 73: 355-82.
6. Hay RT, (2005) SUMO: A history of modification. Mol Cell 18: 1-12.
7. Eaton EM, Sealy L, (2003) Modification of CCAAT/Enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J Biol Chem 278: 33416-33421.
8. Descombes P, Schibler U, (1991) A liver enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 3: 569-579.
9. Calkhoven CF, Muller C, Leutz A, (2000) Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev 14: 1920-32.
10. Lincoln AJ, Monczak Y, Williams SC, Johnson PF, (1998) Inhibition of CCAAT/enhancer-binding protein alpha and beta translation by upstream open reading frames. J Biol Chem 273: 9552-60.
11. Baer M, Johnson PF, (2000) Generation of truncated C/EBPbeta isoforms by in vitro proteolysis. J Biol Chem 275: 26582-90.
12. Robinson GW, Johnson PF, Hennighausen L, Sterneck E, (1998) The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 12: 1907-1916.
13. Seagroves T, Krnacik S, Raught B, Gay J, Burgess-Beusse B, et al. (1998) C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 12: 1917-1928.
14. Abreu MM, Sealy L, (2010) The C/EBPbeta isoform, liver-inhibitory protein (LIP), induces autophagy in breast cancer cell lines. Exp Cell Res 16: 3227-38.
15. Bundy LM, Sealy L, (2003) CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22: 869-883.
16. Bundy L, Wells S, Sealy L, (2005) C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells. Mol Cancer 4: 43.
17. Eaton EM, Hanlon M, Bundy L, Sealy L, (2001) Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. J of Cell Physiol 189: 91-105.
18. Koslowski M, Tureci O, Biesterfeld S, Seitz G, Huber C, et al. (2009) Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer binding protein beta (C/EBPbeta) isoform 2*. J Biol Chem 284: 28607-15.
19. Kowenz-Leutz E, Leutz A, (1999) A C/EBPbeta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 4: 735-43.
20. Sebastian T, Malik R, Thomas S, Sage J, Johnson PF, (2005) C/EBPbeta cooperates with RB:E2F to implement Ras (V12)-induced cellular senescence. EMBO J 24: 3301-3312.
21. Kuilman T, Michaloglou C, Vredeveld L, Dourma S, van Doom R, et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
22. Atwood AA, Sealy L, (2010) Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence. Oncogene 9: 6004-15.
23. Atwood AA, Sealy L, (2011) C/EBPbeta's role in determining Ras-induced senescence or transformation. Small GTPases 2: 1-6.
24. Gill G, (2005) Something about SUMO inhibits transcription. Curr Opin Genet Dev 15: 536-551.
25. Yang SH, Sharrocks AD, (2004) SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 13: 611-617.
26. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, et al. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-63.
27. Hollenbach AD, Sublett JE, McPherson CJ, Grosveld G, (1999) The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J 18: 702-3711.
28. Vanhatupa S, Ungureanu D, Paakkunainen M, Silvennoinen O, (2008) MAPK-induced Ser727 phosphorylation promotes SUMOylation of STAT1. Biochem J 409: 179-185.
29. Yamashita D, Yamaguchi T, Shimizu M, Nakata N, Hirose F, et al. (2004) The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain. Genes Cells 11: 1017-29.
30. Kang J, Gocke CB, Yu H, (2006) Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochemistry 7: 5.
31. Gregoire S, Tremblay AM, Xiao L, Yang Q, Ma K, et al. (2006) Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J Biol Chem 281: 4423-33.
32. Vu E, Kraus RJ, Mertz JE, (2007) Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. Biochemistry 46: 9795-804.
33. Malaney S, Daly R, (2001) The Ras signaling pathway in mammary tumorigenesis and metastasis. J Mam Gland Biol and Neopl 6: 101-113.
34. Hanlon M, Sturgill TW, Sealy L, (2001) ERK2- and p90Rsk2 -dependent pathways regulate the CCAAT/Enhancer-binding protein-beta with serum response factor. J Biol Chem 276: 38449-38456.
35. Shuman JD, Sebastian T, Kaldis P, Copeland TD, Zhu S, et al. (2004) Cell Cycle-Dependent Phosphorylation of C/EBPbeta Mediates Oncogenic Cooperativity between C/EBPbeta and H-RasV12. Mol Cell Biol 24: 7380-7391.
36. Li X, Woo Kim J, Gronborg M, Urlaub H, Lane MD, et al. (2007) Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. Proc Natl Acad Sci 104: 11597-11602.
37. Engelman JA, Lisanti MP, Scherer PE, (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273: 32111-32120.
38. Horie R, Ishida T, Maruyama-Nagai M, Ito K, Watanabe M, et al. (2007) TRAF activation of C/EBPbeta (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages. Microbes Infect 6: 721-8.
39. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, et al. (1998) High efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58: 14-19.